Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 2,737-2,748 of 10,612
Drug study icon
CompletedNCT00330174

Acamprosate in Alcoholics With Comorbid Anxiety or Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Depression, AnxietyDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression, Anxiety
Drug study icon
CompletedNCT00511940

Acamprosate in the Treatment of Binge-Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Eating disordersDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Eating disorders
Drug study icon
CompletedNCT00360594

Acamprosate Initiated During Alcohol Detoxification

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Addiction
Drug study icon
CompletedNCT00466661

Acamprosate vs. Placebo in Bipolar Alcoholics

This summary needs review. Please check the official study record and contact the research team for details.

In United States
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity
Device study icon
Enrolling By InvitationNCT07155096

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Device study icon
Active Not RecruitingNCT07226011

Accelerated High-Dose tDCS for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionDeviceFrom 18 Years to 70 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Depression
Device study icon
Active Not RecruitingNCT05849402

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolarity type II

This study is looking at care and outcomes for people with Bipolarity II, Most Recent Episode Major Depressive, Current Depressive Episode, or Treatment Resistant Depression. Some participants may receive Sham aiTBS instead of the study treatment, and direct benefit is not guaranteed.

In United States
Depression, BipolarityDeviceFrom 18 Years to 80 Years
Countries
United States
Sponsor
Stanford University
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.